Physical Activity in People With Sequelae of Poliomyelitis

Status Recruiting

Clinical Trial Summary

People with disabilities are less physically active than the general population. At present, the physical activity level of people with poliomyelitis sequelae and their barriers to physical activity are unknown. The aim of this study is to describe the physical activity level of people with poliomyelitis sequelae and their barriers to physical activity.

Clinical Trial Description

This is a cross-sectional, monocentric, cohort study of subjects with poliomyelitis sequelae followed in a Physical Medicine and Rehabilitation Department. All consecutive eligible outpatient subjects consulting to the Physical Medicine and Rehabilitation Department of our university hospital will be included. Data will be collected from the patients' medical records, in particular data related to their clinical, radiological, biological and physiological examinations. It is an ancillary study to the NO-AGING study. ;

Study Design

Related Conditions & MeSH terms

Poliomyelitis

Clinical Trial Details

NCT number	NCT05303545
Study type	Observational
Source	Institut de Sante Parasport Connecte Synergies
Contact	François Genêt, MD-PhD
Phone	+33 1 47 10 70 82
Email	francois.genet@aphp.fr
Status	Recruiting
Phase
Start date	May 1, 2022
Completion date	December 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04989231` - An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses
Completed	`NCT00352963` - Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).	Phase 3
Recruiting	`NCT03890497` - Assessment of Poliovirus Type 2 Immunogenicity of One and Two Dose Schedule With IPV and fIPV When Administered at 9-13 Months of Age in Bangladesh	Phase 4
Completed	`NCT00753649` - Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants	Phase 4
Completed	`NCT04693286` - Clinical Trial of Novel OPV2 Vaccine	Phase 2
Completed	`NCT02847026` - Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study	Phase 4
Completed	`NCT02189811` - Polio End-game Strategies - Poliovirus Type 2 Challenge Study	Phase 4
Completed	`NCT01444781` - Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants	Phase 3
Completed	`NCT01214889` - Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.	Phase 3
Completed	`NCT00879827` - Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants	Phase 3
Completed	`NCT01457495` - Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly	Phase 2
Completed	`NCT02853929` - Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery	Phase 4
Completed	`NCT03614702` - Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV	Phase 3
Terminated	`NCT04063150` - Immunogenicity of Intramuscular and Intradermal IPV	Phase 4
Completed	`NCT04614597` - A Study on Immunity Duration Against Polio Over 18 Months Infants After 2 or 3 Primary Doses Sabin IPV in China
Completed	`NCT03239496` - A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV	Phase 3
Completed	`NCT04544787` - A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates	Phase 2
Completed	`NCT02985320` - Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine	Phase 1/Phase 2
Completed	`NCT02291263` - Immunogenicity of Intramuscular Inactivated Poliovirus Vaccine	Phase 3
Completed	`NCT02274285` - DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants	Phase 3